Nephros reports record FY2021 revenue of $10.4M, guides FY2022 $13-13.5M

NEPHROS INC

Preliminary FY2021 net revenue $10.4M (+21% YoY); Q4 revenue $2.8M (+18% YoY).
Issued FY2022 revenue guidance of $13.0M to $13.5M, representing 25-30% growth.
Ended Q4 2021 with ~$7M cash; reinstated revenue guidance practice.
Pathogen Detection Systems revenue $188k in 2021; expects >200% growth in 2022.
Subsidiary SRP received FDA info request for HDF Assist; expects 510(k) clearance H1 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.